Development Center for Biotechnology (DCB) is founded in 1984 and has its mission to facilitate the ongoing growth and development of Taiwan's biotech industry. To this end, we strive to act as the industry's partner, coordinating resources among government, academia and private companies. DCB plays a key role in building and upgrading Taiwan's biomedical infrastructure, developing critical technologies and culturing Taiwan's professional workforce, and also contually fosters international partnerships and collaborations with research institutes and global biopharmaceuticals throughout Asia and the world.
In both fields of small molecules and biologics, we may provide plenty of drug development services as well as new drug candidates for out-licensing, which are in the preclinical stage, and platforms which can be adopted in your design of drugs.
Info of said candidates for out-licensing, please refer to:
DCB Technology promotion：https://www.dcb.org.tw/posts/729
Cooperation projects and needs
1. Process development for T-cell & CAR-T therapy: Looking for licensee or clinical partners.
2. iPSC & MSC: Looking for clinical partners for the development of various applications; academic/commercial R&D members who have demands on iPSC.